CN101631464A - 用于治疗过度增殖疾病和血管发生相关性疾病的2,3-二氢咪唑并[1,2-c]喹唑啉取代衍生物 - Google Patents

用于治疗过度增殖疾病和血管发生相关性疾病的2,3-二氢咪唑并[1,2-c]喹唑啉取代衍生物 Download PDF

Info

Publication number
CN101631464A
CN101631464A CN200780044849A CN200780044849A CN101631464A CN 101631464 A CN101631464 A CN 101631464A CN 200780044849 A CN200780044849 A CN 200780044849A CN 200780044849 A CN200780044849 A CN 200780044849A CN 101631464 A CN101631464 A CN 101631464A
Authority
CN
China
Prior art keywords
methoxyl
glyoxalidine
quinazoline
morpholine
vitamin
Prior art date
Application number
CN200780044849A
Other languages
English (en)
Chinese (zh)
Inventor
M·亨特曼
J·伍德
W·斯科特
M·米歇尔斯
A-M·坎贝尔
A-M·比利翁
R·B·罗利
A·雷德曼
Original Assignee
拜耳先灵医药股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US87309006P priority Critical
Priority to US60/873,090 priority
Application filed by 拜耳先灵医药股份有限公司 filed Critical 拜耳先灵医药股份有限公司
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39492563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101631464(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of CN101631464A publication Critical patent/CN101631464A/zh

Links